Kang SB - Search Results

1

Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes.

Kim MH, Seo SS, Song YS, Kang DH, Park IA, Kang SB, Lee HP. Kim MH, et al. Among authors: kang dh, kang sb. Gynecol Oncol. 2003 Jul;90(1):83-90. doi: 10.1016/s0090-8258(03)00224-5. Gynecol Oncol. 2003. PMID: 12821346

2

Multiple HPV infection in cervical cancer screened by HPVDNAChip.

Lee SA, Kang D, Seo SS, Jeong JK, Yoo KY, Jeon YT, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Lee SA, et al. Among authors: kang d, kang sb. Cancer Lett. 2003 Aug 20;198(2):187-92. doi: 10.1016/s0304-3835(03)00312-4. Cancer Lett. 2003. PMID: 12957357

3

Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.

Seo SS, Song YS, Kang DH, Park IA, Bang YJ, Kang SB, Lee HP. Seo SS, et al. Among authors: kang dh, kang sb. Gynecol Oncol. 2004 Mar;92(3):927-35. doi: 10.1016/j.ygyno.2003.11.055. Gynecol Oncol. 2004. PMID: 14984962

4

p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.

Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY, Kang SB, Lee HP. Roh JW, et al. Among authors: kang sb. Gynecol Oncol. 2004 May;93(2):499-505. doi: 10.1016/j.ygyno.2004.02.005. Gynecol Oncol. 2004. PMID: 15099969

5

[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.

Kim S, Chung JK, Kang SB, Kim MH, Jeong JM, Lee DS, Lee MC. Kim S, et al. Among authors: kang sb. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):196-201. doi: 10.1007/s00259-003-1367-y. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129701 Clinical Trial.

6

Cyclooxygenase-2 and p53 expressions in endometrial cancer.

Jeon YT, Kang S, Kang DH, Yoo KY, Park IA, Bang YJ, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Jeon YT, et al. Among authors: kang s, kang dh, kang sb. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1538-42. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15342458

7

Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.

Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP. Kang S, et al. Among authors: kang gh, kang sb. Gynecol Oncol. 2005 Jan;96(1):173-80. doi: 10.1016/j.ygyno.2004.09.031. Gynecol Oncol. 2005. PMID: 15589597

8

Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.

Kang S, Kim YB, Kim MH, Yoon KS, Kim JW, Park NH, Song YS, Kang D, Yoo KY, Kang SB, Lee HP. Kang S, et al. Among authors: kang d, kang sb. Cancer Lett. 2005 Jan 10;217(1):11-6. doi: 10.1016/j.canlet.2004.06.053. Cancer Lett. 2005. PMID: 15596291

9

Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women.

Ju W, Kang S, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Ju W, et al. Among authors: kang s, kang sb. Cancer Lett. 2005 Jan 20;217(2):191-6. doi: 10.1016/j.canlet.2004.08.032. Cancer Lett. 2005. PMID: 15617836

10

Tubulo-villous adenoma of the vagina.

Lee SE, Park NH, Park IA, Kang SB, Lee HP. Lee SE, et al. Among authors: kang sb. Gynecol Oncol. 2005 Feb;96(2):556-8. doi: 10.1016/j.ygyno.2004.10.041. Gynecol Oncol. 2005. PMID: 15661252 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters